Urinary Cystatin C as a Potential Risk Marker for Cardiovascular Disease and Chronic Kidney Disease in Patients with Obesity and Metabolic Syndrome | Zendy

Noriko SatohAsahara | Zendy; Takayoshi Suganami | Zendy; Takafumi Majima | Zendy; Kazuhiko Kotani | Zendy; Yasuhisa Kato | Zendy; Rika Araki | Zendy; Kazunori Koyama | Zendy; Taiichiro Okajima | Zendy; Makito Tanabe | Zendy; Mariko Oishi | Zendy; Akihiro Himeno | Zendy; Shigeo Kono | Zendy; Akira Sugawara | Zendy; Masakazu Hattori | Zendy; Yoshihiro Ogawa | Zendy; Akira Shimatsu | Zendy

Open Access

Urinary Cystatin C as a Potential Risk Marker for Cardiovascular Disease and Chronic Kidney Disease in Patients with Obesity and Metabolic Syndrome

Author(s) -

Noriko SatohAsahara,

Takayoshi Suganami,

Takafumi Majima,

Kazuhiko Kotani,

Yasuhisa Kato,

Rika Araki,

Kazunori Koyama,

Taiichiro Okajima,

Makito Tanabe,

Mariko Oishi,

Akihiro Himeno,

Shigeo Kono,

Akira Sugawara,

Masakazu Hattori,

Yoshihiro Ogawa,

Akira Shimatsu

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.04830610

Subject(s) - medicine , cystatin c , metabolic syndrome , obesity , disease , kidney disease , urinary system , endocrinology , renal function

Obesity and metabolic syndrome (MS) increase the risk of cardiovascular disease (CVD), chronic kidney disease (CKD), and all-cause mortality. Serum cystatin C (S-CysC), a marker of GFR, has been shown to be associated with CVD and CKD. This study was designed to elucidate the association of urinary CysC (U-CysC), a marker of renal tubular dysfunction, with CVD and CKD risk factors in patients with obesity and MS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research